Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 88 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 7863047

    Intracorporeal medicaments for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  2. US 7863262

    Nitroxyl progenitors in the treatment of heart failure

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  3. US 7863414

    Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

    The Board of Regents of the University of Texas System · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  4. US 7862811

    Protease inhibition for prevention or treatment of heart failure

    The Regents of the University of Colorado · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  5. US 7855190

    Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration

    TEVA WOMEN'S HEALTH, INC. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

  6. US 7850970

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

    The Regents of the University of Colorado · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

  7. US 7851506

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

  8. US 7846664

    Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

    The Regents of the University of California · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted

  9. US 7838531

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  10. US 7829279

    Compositions and methods for diagnosis and treatment of epilepsy

    The Regents of the University of California · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  11. US 7825102

    Treatment of dry eye conditions

    CAN-FITE BIOPHARMA LTD. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  12. US 7825092

    Dendroaspis natriuretic peptide for treatment of cancer

    United States Department of Veteran Affairs · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  13. US 7815914

    Methods for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  14. US 7816324

    Composition and method for the treatment of diseases affected by a peptide receptor

    The Board of Regents of the University of Texas System · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  15. US 7815921

    Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy

    Ludwig-Maximilians-Universitat Munchen · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  16. US 7811996

    Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection

    The Regents of the University of California · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted

  17. US 7807781

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

    The Regents of the University of Colorado · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  18. US 7803380

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

  19. US 7803940

    Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases

    Takeda Pharmaceutical Company Limited · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

  20. US 7799329

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Sep 21, 2010 · Expires Sep 16, 2030

    granted

  21. US 7784616

    Dispenser for progestin used for acute maintenance treatment of DUB

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted

  22. US 7781449

    Trospium chloride treatment method

    Supernus Pharmaceuticals, Inc. · Granted Aug 24, 2010 · Expires Aug 19, 2030

    granted

  23. US 7776883

    Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  24. US 7776827

    Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome

    ImmuneRegen Biosciences, Inc. · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.